Nuvectis Pharma (NVCT) Return on Assets (2022 - 2026)
Nuvectis Pharma (NVCT) reported Return on Assets of 0.01% for Q1 2026, up 1.0% on a YoY basis from 0.01% in Q1 2025, and down 17.87% sequentially from 0.01% in Q4 2025.
Nuvectis Pharma (NVCT) Return on Assets (2022 - 2026) Analysis & Trends
Nuvectis Pharma (NVCT) has 5 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.
- For the quarter ending Q1 2026, Return on Assets rose 1.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (up 1.0% YoY), and the FY2025 full-year result was 0.01%, up 1.0% from the prior year.
- Return on Assets eased to 0.01% in Q1 2026, from 0.01% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.01% in Q4 2025 to a low of 0.03% in Q1 2024.
- A 5-year average of 0.02% and a median of 0.02% in 2025 frame the typical range for Return on Assets.
- Across the five-year window, Return on Assets slipped 2 bps in 2023 and grew 2 bps in 2025, its largest moves.
- Tracing NVCT's Return on Assets over 5 years: stood at 0.02% in 2022, then tumbled by 102 bps to 0.03% in 2023, then climbed by 12 bps to 0.03% in 2024, then soared by 67 bps to 0.01% in 2025, then dropped by 18 bps to 0.01% in 2026.
- Business Quant data shows NVCT's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.02% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -0.69% |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -0.01% |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -0.80% |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 0.00% |
| 10 | Nuvectis Pharma | 453.54 Mn | 453.54 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | -0.03% |
| Jun 30, 2024 | -0.03% |
| Mar 31, 2024 | -0.03% |
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.02% |